BeiGene
BGNE
#816
Rank
C$34.09 B
Marketcap
$295.59
Share price
-0.63%
Change (1 day)
28.64%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yield history for this company